Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic evidence for GLP1R agonists in non-ischaemic heart failure.

ESC heart failure·2026
Same author

Direct Oral Anticoagulant Protein Targets and Risk of Cerebral Venous Thrombosis: A Mendelian Randomization Study.

Neurology·2026
Same author

Assessing the Causal Effects of Environmental Tobacco Smoke Exposure: A meta-analytic Mendelian randomisation study.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Observed Versus Predicted Stroke Risk After Transient Ischemic Attack: A Post Hoc Analysis of a Randomized Clinical Trial.

Journal of the American Heart Association·2026
Same author

Limitations to causal inference in observational studies of PFO closure.

European stroke journal·2026
Same author

Genetically Predicted Levels of Lipoprotein(a) and Risk of Cerebrovascular Disease.

Journal of the American Heart Association·2026

Related Experiment Video

Updated: Jul 14, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.1K

Adiposity and Functional Outcome After Ischemic Stroke: A Mendelian Randomization Study

Mengmeng Wang1, Zhizhong Zhang1, Iyas Daghlas1

  • 1From the Department of Neurology (M.W., X.L.), The Third Affiliated Hospital of Soochow University, Changzhou, China; Department of Neurology (Z.Z.), Jinling Hospital, Medical School of Nanjing University, China; Department of Neurology (I.D.), University of California San Francisco; Department of Epidemiology and Biostatistics (D.G.), School of Public Health, St Mary's Hospital, Imperial College London, United Kingdom; and Department of Integrated Traditional Chinese and Western Medicine (D.L.), The Third Affiliated Hospital of Soochow University, Changzhou, China.

Neurology
|January 5, 2024
PubMed
Summary

Abdominal adiposity, measured by waist-to-hip ratio, is linked to poor functional recovery after ischemic stroke. Body mass index, however, showed no such association in this genetic study.

More Related Videos

Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue
06:56

Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue

Published on: July 21, 2023

2.2K
Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
05:32

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Published on: August 11, 2023

1.9K

Related Experiment Videos

Last Updated: Jul 14, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.1K
Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue
06:56

Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue

Published on: July 21, 2023

2.2K
Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
05:32

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Published on: August 11, 2023

1.9K

Area of Science:

  • Genetics
  • Epidemiology
  • Neurology

Background:

  • Investigating the causal link between adiposity and post-stroke functional outcomes is crucial for understanding recovery.
  • Abdominal adiposity (waist-to-hip ratio, WHR) and overall adiposity (body mass index, BMI) are key areas of interest.

Approach:

  • Utilized Mendelian randomization to assess causal relationships between WHR, BMI, and ischemic stroke functional outcome.
  • Employed large-scale genome-wide association study data for genetic instruments and extracted outcome data from a relevant network.
  • Analyzed functional outcome using the modified Rankin Scale (mRS) at 3 months post-stroke.

Key Points:

  • Genetically predicted higher WHR was significantly associated with unfavorable functional outcome (mRS 3-6) after ischemic stroke.
  • Genetically predicted BMI did not show a significant association with unfavorable functional outcome post-stroke.
  • Sensitivity analyses confirmed the directional consistency of the WHR findings.

Conclusions:

  • This study provides genetic evidence that abdominal adiposity negatively impacts functional recovery following ischemic stroke.
  • Findings suggest targeting abdominal fat may be beneficial for improving stroke outcomes.